+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bristol-Myers Squibb - logo

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

Drug Discovery Outsourcing Market Report 2023-2033 - Product Thumbnail Image

Drug Discovery Outsourcing Market Report 2023-2033

  • Report
  • June 2023
  • 389 Pages
  • Global
From
Idiopathic Pulmonary Fibrosis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Thumbnail Image

Idiopathic Pulmonary Fibrosis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • January 2026
  • 185 Pages
  • Global
From
Small Molecule Active Pharmaceutical Ingredient Market Report 2025 - Product Thumbnail Image

Small Molecule Active Pharmaceutical Ingredient Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Idiopathic Pulmonary Fibrosis Treatment Market Report by Drug Class (MAPK Inhibitors, Tyrosine Inhibitors, Autotaxin Inhibitors), End User (Hospitals, Long-Term Care Facilities, and Others), and Region 2025-2033 - Product Thumbnail Image

Idiopathic Pulmonary Fibrosis Treatment Market Report by Drug Class (MAPK Inhibitors, Tyrosine Inhibitors, Autotaxin Inhibitors), End User (Hospitals, Long-Term Care Facilities, and Others), and Region 2025-2033

  • Report
  • February 2025
  • 150 Pages
  • Global
From
Orphan Drugs - Global Strategic Business Report - Product Thumbnail Image

Orphan Drugs - Global Strategic Business Report

  • Report
  • February 2026
  • 409 Pages
  • Global
From
Catecholamines - Global Strategic Business Report - Product Thumbnail Image

Catecholamines - Global Strategic Business Report

  • Report
  • February 2026
  • 372 Pages
  • Global
From
Blarcamesine Market - Global Strategic Business Report - Product Thumbnail Image

Blarcamesine Market - Global Strategic Business Report

  • Report
  • February 2026
  • 370 Pages
  • Global
From
Levodopa Market - Global Strategic Business Report - Product Thumbnail Image

Levodopa Market - Global Strategic Business Report

  • Report
  • February 2026
  • 377 Pages
  • Global
From
Facial Palsy - Global Strategic Business Report - Product Thumbnail Image

Facial Palsy - Global Strategic Business Report

  • Report
  • February 2026
  • 367 Pages
  • Global
From
Multiple Sclerosis Drugs - Global Strategic Business Report - Product Thumbnail Image

Multiple Sclerosis Drugs - Global Strategic Business Report

  • Report
  • February 2026
  • 235 Pages
  • Global
From
Central Nervous System Therapeutics Market - Global Strategic Business Report - Product Thumbnail Image

Central Nervous System Therapeutics Market - Global Strategic Business Report

  • Report
  • February 2026
  • 395 Pages
  • Global
From
Asperger Syndrome - Global Strategic Business Report - Product Thumbnail Image

Asperger Syndrome - Global Strategic Business Report

  • Report
  • February 2026
  • 204 Pages
  • Global
From
Plexiform Neurofibromas Treatment Market - Global Strategic Business Report - Product Thumbnail Image

Plexiform Neurofibromas Treatment Market - Global Strategic Business Report

  • Report
  • February 2026
  • 372 Pages
  • Global
From
Neuralgia Treatment - Global Strategic Business Report - Product Thumbnail Image

Neuralgia Treatment - Global Strategic Business Report

  • Report
  • February 2026
  • 276 Pages
  • Global
From
Tourette Syndrome Treatment Market - Global Strategic Business Report - Product Thumbnail Image

Tourette Syndrome Treatment Market - Global Strategic Business Report

  • Report
  • February 2026
  • 186 Pages
  • Global
From
Neurodegenerative Diseases Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Neurodegenerative Diseases Therapeutics - Global Strategic Business Report

  • Report
  • February 2026
  • 387 Pages
  • Global
From
Autoinjectors: Intellectual Property Landscape, Featuring Historical and Contemporary Patent Filing Trends, Prior Art Search Expressions, Patent Valuation Analysis, Patentability, Freedom to Operate, Pockets of Innovation, Existing White Spaces, and Claims Analysis - Product Thumbnail Image

Autoinjectors: Intellectual Property Landscape, Featuring Historical and Contemporary Patent Filing Trends, Prior Art Search Expressions, Patent Valuation Analysis, Patentability, Freedom to Operate, Pockets of Innovation, Existing White Spaces, and Claims Analysis

  • Report
  • January 2023
  • 205 Pages
  • Global
From
HP (High Potency) APIs Market Report 2025 - Product Thumbnail Image

HP (High Potency) APIs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Cancer Therapies - Global Strategic Business Report - Product Thumbnail Image

Cancer Therapies - Global Strategic Business Report

  • Report
  • February 2026
  • 590 Pages
  • Global
From
Branded PAH Therapeutics Market (2023 Edition) - Analysis By Drug Class, Route of Administration, Distribution Channel, By Region, By Country: Market Insights and Forecast (2019-2029) - Product Thumbnail Image

Branded PAH Therapeutics Market (2023 Edition) - Analysis By Drug Class, Route of Administration, Distribution Channel, By Region, By Country: Market Insights and Forecast (2019-2029)

  • Report
  • November 2023
  • 250 Pages
  • Global
From
Loading Indicator